NZ200281A - Production of solid sodium amoxicillin - Google Patents

Production of solid sodium amoxicillin

Info

Publication number
NZ200281A
NZ200281A NZ200281A NZ20028182A NZ200281A NZ 200281 A NZ200281 A NZ 200281A NZ 200281 A NZ200281 A NZ 200281A NZ 20028182 A NZ20028182 A NZ 20028182A NZ 200281 A NZ200281 A NZ 200281A
Authority
NZ
New Zealand
Prior art keywords
amoxicillin
butanol
sodium
spray
aqueous
Prior art date
Application number
NZ200281A
Inventor
J H Grossman
D L Warner
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ200281A publication Critical patent/NZ200281A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/14Preparation of salts
    • C07D499/16Preparation of salts of alkali or alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number £00281 <br><br> 2002 SI <br><br> Priority Dc: i <br><br> Ccrr:;:!;:o Specification Filed:..$.'..tf.:.3e?... <br><br> liDKML.. <br><br> i5.!^-. Journal, No. 1565 <br><br> p? n ft * (Pi ?A umv <br><br> \M M r#J <br><br> Patents Form No.5 <br><br> NEW ZEALAND PATENTS ACT 1953 COMPLETE SPECIFICATION <br><br> "PRODUCTION OF SODIUM AMOXICILLIN" <br><br> -I-jWE BRISTOL-MYERS COMPANY, a corporation organised and existing under the laws of the State of Delaware, U.S.A. of 345 Park Avenue,.New York, N.Y. 10022, U.S.A. <br><br> hereby declare the invention, for which -i/we pray that a patent may be granted to me/us,-and the method by which it is to be performed, to be particularly described in and by the following-statement <br><br> -1- <br><br> -q\ <br><br> to \ <br><br> 2 00281 <br><br> _ p _ <br><br> The present invention concerns the production sodium amoxicillin by the process of spray-solution of sodium amoxicillin in a mixture and t-butanol. <br><br> Solid sodium amoxicillin has been prepared by precipitation (as in U.K. 1,241,8^ and U.K. 1,286,199) <br><br> but on a commercial scale the product is found to be unsatisfactory because of contamination caused by residual reagents such as triethylamine or sodium 2-ethylhexanoate or excessive amounts of residual solvent. Solid sodium ampicillin has also been prepared by freeze-drying (as in U.K. 1,527,557 and U.K. 1,5^5*317) "but this requires extremely expensive equipment to produce the quantity needed for commercial use; in addition the extremely necessary low temperatures make the procedure require very long periods of time which reduces the output from any given piece of equipment. <br><br> In conducting the process of the present invention use was made of a closed cycle spray dryer; major components of this apparatus are drying chamber, product cyclone, <br><br> exhaust fan, condenser/scrubber (impingement plate, glycol cooled), nitrogen fan, heat exchanger (Dowtherm) and feed pump. The apparatus was set up for concurrent operation with cyclone prod\ict discharge. The unit was first purged with nitrogen to reduce the level of oxygen to a safe level so that the solvent mixture could be charged to the condenser (this allowed steady state drying conditions to be reached quickly). The unit was then equilibrated to the desired inlet temperature, gas flowrate, condenser temperature, etc. The feed (sodium amoxicillin in aqueous t-butanol) was then pumped through a spray nozzle at the top of the drying chairber. Dry product and gas were discharged through the bottom to be separated in a cyclone. <br><br> of solid drying a of water <br><br> 2 0 0 2 3 T <br><br> -3- <br><br> Test Conditions and Results Using Aqueous t-butaonl <br><br> Run A B C D <br><br> Dissolution Amoxicillin Trihydrate, kg. <br><br> NaOH (mol ratio) <br><br> Approx. Temp. °C. <br><br> Time (min.) <br><br> Final pH Feed volume, 1. <br><br> 6.0 1. 02 25 10 9-2 32 <br><br> 5-0 1.02 25 11 9-31 27 <br><br> 6.0 1.02 <br><br> 25 9 <br><br> 9.15 <br><br> 33 <br><br> 5.0 1. 02 <br><br> 25 <br><br> 5 <br><br> 9-2 <br><br> 26 <br><br> Drying Step <br><br> Nozzle Type Pressure Pressure Rotary Rotary <br><br> Pressure (psig) ~l6o 175 20,000 rpm 20,000 rpm <br><br> Temperatures (°C. ) • <br><br> Inlet <br><br> 200 <br><br> 180 <br><br> 180 <br><br> 180 <br><br> Outlet N2 <br><br> 117 <br><br> 116 <br><br> 117 <br><br> 125 <br><br> Condenser <br><br> 2 <br><br> 3 <br><br> 0 <br><br> 1-2 <br><br> Feed Rate (lph) <br><br> '10.2 <br><br> 32.3 <br><br> 38.5 <br><br> 28 <br><br> Total Drying <br><br> Time (min) <br><br> 56 <br><br> U6 <br><br> 56 <br><br> HQ <br><br> 2 002 81 <br><br> -4- <br><br> Product Data io H20 (KF) 1.8; 1.4 2.5; 2.7 1.5; 1.1-2; 1-5 <br><br> Bulk density (g/cnr) 0.43 0.53 0.26 0.26 <br><br> Chem. potency 830 786 894 858 <br><br> Bioassay (as is) 768 732 844 8l6 1^ Absorbing <br><br> Substances ^ . 6.9 9.7 4.2 4.^ <br><br> pH (3$ in H20) 8.7 8.7 8.7 8.7 <br><br> $ t-BuOH 0.8 0.8 0.9 0.9 <br><br> Klett (10# with . 72 59 65 80 <br><br> blue filter) <br><br> Determined on an anhydrous solvent free basis using the procedure of the British Pharmacopeia to measure contamination by penicilloic acid or dimers or the like. <br><br> The purity and physical properties of the resulting four batches of solid., spray-dried sodium amoxicillin were suitable for commercial use after sterilization as by ethylene oxide. <br><br> In the preparation of the feed to the dryer (Dissolution step above) micropulverized amoxicillin trihydrate (potency 845 mcg/mgm) was slurried in aqueous t-butanol using 2.4 1. <br><br> water and 1.5 1- t-butanol per kg. of amoxicillin trihydrate and kept at 25°C. To this slurry 1.97 N aqueous sodium hydroxide was added continuously using about 2$ excess <br><br> (1.23 l.Ag). <br><br> /—\ <br><br> 2 002 81 <br><br> Run E_ F G_ II <br><br> Dissolu l.ion Amoxi cillin <br><br> Trihydrate, kg. 6.0 6.0 0.0 6.0 <br><br> Drying Step <br><br> Nozzle Type Pressure (psig) <br><br> Temperatures (°C.) Inlet N2 <br><br> Outlet N^ <br><br> Pressure Pressure Pressure Pressure <br><br> 850 l'l 56/1500 1900 1500 . <br><br> 183/1814 181/183 190/191 180 <br><br> 82/115 115/117 115 115 <br><br> Product Data <br><br> Maximum Particle Size in microns <br><br> "X <br><br> Bulk density (g/cnr) <br><br> 90% 50% 10% <br><br> Klett (10# with blue filter) <br><br> $ HgO (KF) <br><br> io t-BuOH <br><br> Chem. Potency, as is Chem. Potency (Anhyd.) Bioassay (as is) Bioassay (Anhyd.) I2 Absorbing <br><br> • 299 <br><br> 65.8 28.1 7.67 <br><br> 74 <br><br> 2.9 <br><br> 1.2 + 1.4 817 865 784 830 <br><br> (1) <br><br> Substances (Anhyd.) <br><br> Substances as is I2 Absorbing <br><br> .271 <br><br> .257 <br><br> .274 <br><br> 43.8 <br><br> 39.1 <br><br> ^5.3 <br><br> 20.5 <br><br> 18.0 <br><br> 42.7 <br><br> 6.73 <br><br> 6.27 <br><br> 3^-7 <br><br> 68 <br><br> 62 <br><br> 6.2 <br><br> 2.5 <br><br> 2.4 <br><br> 1-9 <br><br> 1.0 <br><br> 1.2 <br><br> 1.2 <br><br> 839 <br><br> 831 <br><br> 846 <br><br> 869 <br><br> 862 <br><br> 873 <br><br> 821) <br><br> 829 <br><br> 824 <br><br> 8511 <br><br> 860 <br><br> 850 <br><br> Determined on an anhydrous solvent free basis using the procedure of the British Pharmacopeia to measure contamination by penicilloic acid or dimers or the like. <br><br> ' * <br><br> -6- 2 002 8 1 <br><br> • Run I_ J K L <br><br> Dissolution Amoxicillin <br><br> Trihydrate, kg. 6.0 6.0 6.0 6.0 <br><br> Drying Step <br><br> Nozzle Type Pressure <br><br> Pressure <br><br> Pressure <br><br> Pressure <br><br> Pressure (psig) <br><br> 1500 <br><br> 1500 <br><br> 1500 <br><br> 1600 <br><br> Temperatures (°C.) <br><br> Inlet N2 <br><br> 180 <br><br> 180 <br><br> 180 <br><br> 201 <br><br> Outlet Ng <br><br> 115 <br><br> 115 <br><br> 115 <br><br> 128 <br><br> Product Data <br><br> Bulk density (g/cnr) <br><br> ro 00 <br><br> .273 <br><br> N/A <br><br> .221 <br><br> Maximum Particle 90# <br><br> J&gt;b.7 <br><br> 44 .8 <br><br> 39-5 <br><br> Size in' microns r~nt <br><br> 17. '1 <br><br> 20.7 <br><br> 21.5 . <br><br> 10# <br><br> 6.27 <br><br> 6.92 <br><br> 7.4 <br><br> Klett (10# with <br><br> 64 <br><br> 68 <br><br> 62 <br><br> 63 <br><br> blue filter) <br><br> # H2O (KF) <br><br> 2.0 <br><br> 1.7 <br><br> 1.6 <br><br> 1.4 <br><br> # t-BuOH <br><br> 1.3 <br><br> 1.3 <br><br> 1.4 <br><br> 1.3 <br><br> Chem. Potency, as is <br><br> 815 <br><br> 817 <br><br> 818 <br><br> 836 <br><br> Chem. Potency (Anhyd.) <br><br> 843 <br><br> 842 <br><br> 843 <br><br> 861 <br><br> Bioassay (as is) <br><br> 800 <br><br> 795 <br><br> 787 <br><br> 832 <br><br> Bioassay (Anhyd.) <br><br> 827 <br><br> 820 <br><br> 811 <br><br> 855 <br><br> I0 Absorbing <br><br> £1 / -1 \ <br><br> (1) <br><br> Substances as xs v ' <br><br> 6.8 <br><br> 7.5 <br><br> 7.6 <br><br> 5-4 <br><br> Ig Absorbing <br><br> Substances (Anhyd.) <br><br> 7-0 <br><br> 7.7 <br><br> 7.8 <br><br> 5-5 <br><br> Determined on an anhydrous solvent free basis using the procedure of the British Pharmacopeia to measureocontamination by penicilloic acid or dimers or the like. <br><br></p> </div>

Claims (11)

<div class="application article clearfix printTableText" id="claims"> <p lang="en"> - 7 -<br><br> 2 002 81<br><br> In the step of spray-drying the pressure is varied to obtain the desired particle size.<br><br> Operation of the spray-drying process under sterile conditions using the pressure nozzle produces sterile solid sodium amoxicillin which can be filled directly into vials under sterile conditions.<br><br> The antibacterial properties and clinical methods of use of amoxicillin are well-known in the medical literature with regard to the oral use of its trihydrate. For parenteral administration it is often preferred to inject an aqueous solution which requires conversion of the insoluble trihydrate to the highly soluble sodium salt as in the process of the present invention. The results of parenteral administration of aqueous sodium amoxicillin have been described, for example, by D.A. Spyker et al., Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral and intramuscular administratioi Antimicrobial Agents and Chemotherapy, _1]_, 132 (19 77) and by S.A. Hill et al., Pharmacokinetics of parenterally administered amoxicillin Journal of Infection 2, 320-332 (1980)<br><br> The inlet temperature is preferably between about 170°C to 210°C the outlet temperature is preferably between the boiling point of the t-butanol/water mixture and about 130°C. The amount of t-butanol that is present in the mixture with water can vary within wide limits but will generally be less than 50% by volume of the total volume of the water/butanol mixture more preferably between about 25% and 40% by volume of the total volume.<br><br> - 8 -<br><br> - 200281<br><br> WHAT WE CLAIM IS<br><br>
1. A process for the production of solid sodium amoxicillin characterized by spray-drying a solution of sodium amoxicillin in aqueous t-butanol.<br><br>
2. The process of Claim 1 in which the inlet temperature is between oboufe- 170°C and about 210°C and the outlet temperature is between the boiling point of the aqueous t-butanol mixture and about 130°C.<br><br>
3. The process of Claim 1 or Claim 2 in which the solution to be spray-dried contains less than 50% by volume of t-butanol.<br><br>
4. A process as claimed in any one of Claims 1 to 3 wherein sodium amoxicillin is prepared by converting a slurry of amoxicillin trihydrate in aqueous t-butanol into sodium amoxicillin using sodium hydroxide.<br><br>
5. A process as claimed in Claim 4 wherein an excess of sodium hydroxide is employed.<br><br>
6. A process as claimed in any one of Claims 1 to 5 wherein the solution to be spray dried contains between 25 to 40% by volume of t-butanol.<br><br>
7. A process as claimed in Claim 6 wherein the amount of t-butanol is 1.5 -1. for each 2.4 1. of water.<br><br>
8. A process as claimed in any one of claims 1 to 7 wherein the pressure is controlled to provide a desired particle size.<br><br>
9. A process as claimed in Claim 1 substantially as described herein in any one of Runs A to L.<br><br> r<br><br>
10. Solid sodium amoxicillin when obtained by the;./-.<br><br> process of any one of Claims 1 to 9. ,/v?<br><br> */v<br><br> - 9 -<br><br> 2<br><br>
11. An injectable conposition prepared from solid sodium amoxicillin as claimed in Claim 10.<br><br> "^orney's'fo'b'the applicants<br><br> </p> </div>
NZ200281A 1981-04-10 1982-04-08 Production of solid sodium amoxicillin NZ200281A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8107247A FR2503710B1 (en) 1981-04-10 1981-04-10 PROCESS FOR PRODUCING SODIUM SALT OF AMOXICILLIN

Publications (1)

Publication Number Publication Date
NZ200281A true NZ200281A (en) 1984-12-14

Family

ID=9257255

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ200281A NZ200281A (en) 1981-04-10 1982-04-08 Production of solid sodium amoxicillin

Country Status (23)

Country Link
JP (1) JPS57179191A (en)
KR (1) KR880001410B1 (en)
AU (1) AU559766B2 (en)
BE (1) BE892451A (en)
CA (1) CA1182108A (en)
CH (1) CH651836A5 (en)
DE (1) DE3213308A1 (en)
DK (1) DK157382A (en)
ES (1) ES511295A0 (en)
FI (1) FI821247L (en)
FR (1) FR2503710B1 (en)
GB (1) GB2096599B (en)
GR (1) GR76106B (en)
IE (1) IE52939B1 (en)
IT (1) IT1148165B (en)
LU (1) LU84007A1 (en)
NL (1) NL8201467A (en)
NO (1) NO821174L (en)
NZ (1) NZ200281A (en)
PT (1) PT74727B (en)
SE (1) SE8202269L (en)
YU (1) YU43132B (en)
ZA (1) ZA822400B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131147B2 (en) * 1983-06-10 1996-12-04 Beecham Group p.l.c. Crystalline amoxycillin salt
IT1255716B (en) * 1992-10-05 1995-11-10 PROCEDURE FOR THE PREPARATION OF STERILE BETA-LACTAMIC ANTIBIOTICS
AT412213B (en) * 2000-05-30 2004-11-25 Sandoz Ag METHOD FOR DRYING AMOXICILLIN OR AMOXICILLIN-CONTAINING, ORAL, SOLID PHARMACEUTICAL COMPOSITIONS USING A GAS WITH A DEFINED GAS HUMIDITY
CN105055169B (en) * 2015-07-11 2019-01-22 鲁南制药集团股份有限公司 A method of preparing Imipenem and Cilasatin Sodium aseptic powdery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1471235A (en) * 1974-09-18 1977-04-21 Beecham Group Ltd Amoxycillin derivatives
GB1527557A (en) * 1976-07-07 1978-10-04 Beecham Group Ltd Process for preparing solid sodium amoxycillin
GB1576731A (en) * 1976-08-10 1980-10-15 Beecham Group Ltd Process for the preparation of sodium amoxycillin
DE2965917D1 (en) * 1978-12-08 1983-08-25 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof

Also Published As

Publication number Publication date
ES8304138A1 (en) 1983-02-16
KR830010116A (en) 1983-12-26
PT74727A (en) 1982-05-01
ES511295A0 (en) 1983-02-16
YU43132B (en) 1989-04-30
AU8045582A (en) 1982-10-14
IE52939B1 (en) 1988-04-13
GB2096599B (en) 1985-01-23
AU559766B2 (en) 1987-03-19
FI821247A0 (en) 1982-04-07
DE3213308A1 (en) 1982-11-11
IE820844L (en) 1983-10-10
JPH0219119B2 (en) 1990-04-27
PT74727B (en) 1985-01-08
SE8202269L (en) 1982-10-11
IT8248188A0 (en) 1982-04-07
NO821174L (en) 1982-10-11
LU84007A1 (en) 1983-02-22
NL8201467A (en) 1982-11-01
FI821247L (en) 1982-10-11
DK157382A (en) 1982-10-11
GR76106B (en) 1984-08-03
IT1148165B (en) 1986-11-26
YU43282A (en) 1985-06-30
FR2503710B1 (en) 1985-07-05
KR880001410B1 (en) 1988-08-01
CH651836A5 (en) 1985-10-15
FR2503710A1 (en) 1982-10-15
BE892451A (en) 1982-09-10
CA1182108A (en) 1985-02-05
JPS57179191A (en) 1982-11-04
GB2096599A (en) 1982-10-20
ZA822400B (en) 1983-02-23

Similar Documents

Publication Publication Date Title
JP3065320B2 (en) Polyamide powder comprising particles having &#34;desert rose&#34; structure and method for producing the same
MXPA05004300A (en) Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes.
NZ200281A (en) Production of solid sodium amoxicillin
US3979520A (en) Preparation of rapidly resorbable glibenclamide
GB1576731A (en) Process for the preparation of sodium amoxycillin
JP5607746B2 (en) Method for producing solid gadobenate dimeglumine complex
US4607029A (en) Novel sodium amoxicillin preparations
JPS61275320A (en) Production of oxymethylene copolymer
FI82188B (en) FRAMEWORK FOR THE FRAMEWORK OF ENTRY, PHARMACEUTICAL PROVISION FOR DISPERSION OF CLORTALIDON.
GB2231266A (en) The preparation of sterile powders of antibiotics
US3299046A (en) Method of preparing anhydrous ampicillin
Bird et al. 628. Polyamides containing carbohydrate residues. Part II. Benzylidenedioxy-derivatives
CA1339422C (en) Crystalline (5r,6s)-2-carbamoyloxymethyl-6-¬(1r)-hydroxyethyl|-2-penem-carboxylic acid and its pharmaceutical formulation
JPH04198137A (en) Production of dried sterile sodium carbonate
KR910000418B1 (en) Process for preparing sodium amoxacillin
US3461161A (en) Water-soluble tetracycline derivatives
US3318893A (en) Hydroxy aluminum nicotinate salicylate and method of preparing the same
US3904600A (en) High-molecular derivative of 2-diethylaminoethyl-para-aminobenzoate hydrochloride and method for preparing it
EP0049928A2 (en) Water soluble derivatives of cephalexin and process for their preparation
CA1280424C (en) Process for the preparation of the modification a of cimetidine
KR810002136B1 (en) Process for preparation of injectable pharmaceutical compositions containing sodium amoxycillin
FI65256C (en) FOERFARANDE FOER FRAMSTAELLNING AV FAST SODIUMAMOXICILLIN
US4851543A (en) Water soluble multicomplex of aminobenzoic acid
JPH1017580A (en) Production of crystalline l-ascorbic 2-phosphorate sodium salt
US3933796A (en) Antibiotics